Send to a Friend Font Size: Increase Decrease

Viking Global Investors

Viking Global Investors 's Portfolio

Last Updated on 5/16/11 @ 05:55pm

Ticker	# of Shares	Price	Value
	143,085,126	$195.32	$27,947,386,811
	120,000,000	$195.32	$23,438,400,000
	75,238,700	$195.32	$14,695,622,884
GE	7,138,176	$323.11	$2,306,416,048
V	7,140,286	$317.36	$2,266,041,165
	9,798,229	$195.32	$1,913,790,089
MU	4,424,339	$370.30	$1,638,332,732
PM	9,055,492	$169.98	$1,539,252,531
	6,639,199	$195.32	$1,296,768,349
	6,524,565	$195.32	$1,274,378,036
View Additional Portfolio Information »

Viking Global Investors is a long/short equity hedge fund. The fund employs a bottom-up fundamental stock-picking strategy for its investments in equities in the U.S. and Europe. It focuses on the financial, telecommunication, media, technology, and consumer sectors. Viking Global Investors is based in New York and was founded in October, 1999 by Andreas Halvorsen, David Ott, and Brian Olson.

Messers. Halvorsen, Ott, and Olson worked together at Tiger Management Corp. All three left Tiger in early 1999.

Login to help us fill in information about this entity.

AbCellera Biologics (ABCL) PT Lowered to $7 at KeyBanc May 8, 2024 09:49AM

AbCellera Reports Q1 2024 Business Results May 7, 2024 04:05PM

AbCellera, Viking Global Investors, and ArrowMark Partners Collaborate to Launch New Biotech Companies May 1, 2024 09:00AM

Form SC 13G/A AbCellera Biologics Inc. Filed by: VIKING GLOBAL INVESTORS LP Feb 14, 2022 06:34PM

Form SC 13G/A AbCellera Biologics Inc. Filed by: VIKING GLOBAL INVESTORS LP Feb 16, 2021 06:37AM

Dec 28, 2020 06:51AM Form SC 13G/A AbCellera Biologics Inc. Filed by: VIKING GLOBAL INVESTORS LP
Dec 21, 2020 05:29PM Form SC 13G AbCellera Biologics Inc. Filed by: VIKING GLOBAL INVESTORS LP

Nasdaq		15000.33
	+57.68	(+0.39%)

S&P 500		4486.55
	+7.02	(+0.16%)

Market Snapshot

Free News Feed